Close×

A wine bottle which incorporates an interactive touchscreen has been released in the US.

Kuvée is a wine service enabled by a ‘smart wine bottle’ which enables drinkers to order wine, view personalised recommendations, and share tips.

The bottle gives winemakers a new direct-to-consumer e-commerce channel and marketing platform, and also gives point-of-consumption analytics.

kegog1yd1aualuo3prgv1

The system comprises a Kuvée bottle and a collection of 750ml Kuvée wines in special bottles.

These are bottled on the same line as standard glass bottles, and contain 48 of the same popular varietals and labels found in retail stores.

To drink wine with Kuvée, users insert a Kuvée wine into the outer Kuvée bottle and pour.

A patented valve system prevents oxygen from touching the wine, keeping it fresh for up to 30 days after opening.

Kuvée has undergone sensory testing with partner wineries such as Bonny Doon Vineyards.

Its founder Randall Grahm was pleased the system enabled him to extend the life of his wines, and communicate more to consumers.

“We can share so much more than what fits on a standard wine label,” he said.

“It's a truly original approach to the industry's current methods of packaging and marketing wine."

Kuvée plans to roll out the concept globally in due course.

This story was sourced from the Active & Intelligent Packaging Association.

Food & Drink Business

Australia’s first social enterprise bakery, The Bread & Butter Project, has graduated its latest group of bakers, with its largest ever cohort marking the program’s 100th graduate.

The University of Sydney and Peking University have launched a Joint Centre for Food Security and Sustainable Agricultural Development, which will support research into improving the sustainability and security of food systems in Australia and China.

Sydney-based biotech company, All G, has secured regulatory approval in China to sell recombinant (made from microbes, not cows) lactoferrin. CEO Jan Pacas says All G is the first company in the world to receive the approval, and recombinant human lactoferrin is “next in line”.